Business

Gelesis Partners with US Telehealth Provider

Gelesis Partners with US Telehealth Provider.

articlePuretech Health PlcDecember 17, 20194/company/puretech-health-plc/news/gelesis-partners-with-us-telehealth-provider
Gelesis Partners with US Telehealth Provider

About this update from Puretech Health Plc

[{"type":"text","content":"\n \nRNS Number : 0690X PureTech Health PLC 17 December 2019  \n\n17 December 2019\nPureTech Health plc\n \nPureTech Health Affiliate Gelesis Announces Partnership with Ro to Support US Commercialisation of PlenityTM\n \nIn addition to collaborating with traditional healthcare providers, Gelesis will leverage Ro's nationwide telehealth services to make Plenity available to patients who don't have an established healthcare provider or prefer a remote interaction\n \nRo provides a personalised end to end telehealth experience from medical diagnosis to the home delivery of prescription and OTC products\n \nPlenity will be the only weight management treatment available through Ro's digital clinics as Ro expands to treat new conditions on its platform\n \nPureTech Health plc (LSE: PRTC) (\"PureTech\"), a clinical stage biotechnology company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, is pleased to note that its affiliate Gelesis today announced that it is partnering with Ro, a leading US telehealth provider, to offer high-quality remote care dedicated to weight management and prescription fulfilment of Plenity. Through the Gelesis-Ro partnership, Plenity will be the first FDA-cleared weight management aid and first primary care product to launch with both traditional healthcare provider and telehealth services, making Plenity available to patients nationwide. Gelesis retains worldwide sales and marketing rights for Plenity and, since FDA clearance, has secured close to $100 million in new capital to support the US commercial launch.\n \nEric Elenko, PhD, chief innovation officer at PureTech, said: \"We are pleased with the progress Gelesis has made towards the broad commercialisation of Plenity, and this partnership with Ro underscores the Gelesis commitment to innovation in healthcare. Through the company's multipronged commercial strategy, Gelesis aims to empower individuals to access care where they are most comfortable - either through traditional providers or via a telehealth experience.\" \n \nThe full text of the announcement from Gelesis is as follows:\n \nGelesis Announces Partnership with Ro on Commercial Launch of PlenityTM\n \nIn addition to collaborating with traditional healthcare providers, Gelesis w...

More updates from Puretech Health Plc